Stock info Integra Lifesciences Holdings Corp | Filter  Basic-Info

Integra Lifesciences Holdings Corp

The past year was a relatively good year for Integra Lifesciences Holdings Corp investors

Over the past year the company' stock gained around 27 percent. Over the past 5 years Integra Lifesciences Holdings Corp' stock rose at around 203 percent in value. Integra Lifesciences Holdings Corp's revenues between 2011 and 2015 were relatively steady and moved between 830,87 million dollars and 882,73 million dollars. The net results between 2011 and 2015 were far from constant and fluctuated between 27,99 million dollars and 6,85 million dollars.

Integra Lifesciences Holdings Corp primarily operates in the health care eq. & services sector. The period from 2006 till the end of 2016 the international sector gained around 102 percent. Since 2011 the sector is 64 percent higher and over the past year plus 102 percent.

Integra Lifesciences Holdings Corp didn't pay out any dividends (in the past 5 years).

Integra Lifesciences Holdings Corp financed with a quite low debt position

As per the end of 2015 the American company's balance sheet equaled 1,77 billion dollars. The total debt of the health care company was at the end of 2015 1,02 billion dollars, which equals around 57,66 percent of the total balance sheet. At the end of 2015 the health care company's stock was traded with a price/earnings-ratio 39. So the stock' value was 39 times the 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a growth stock.

At the end of 2015 the American company's market capitalization equaled around 2,28 billion dollars. At the end of 2015 the American company had around 34,5 million stocks listed.

All Integra Lifesciences Holdings Corp's financial reports are available here. More information about Integra Lifesciences Holdings Corp can be found it's website. .